Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ΔureC hly+ mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis

Infection and Immunity

Volumn 77, Issue 2, 2009, Pages 622-631

  Tehilian, Elma Z ^a,c   Desel, Christiane ^b   Forbes, Emily K ^a   Bandermann, Silke ^b   Sander, Clare R ^a   Hill, Adrian V S ^a   McShane, Helen ^a   Kaufmann, Stefan H E ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MODIFIED VACCINIA VIRUS ANKARA EXPRESSING MYCOBACTERIUM TUBERCULOSIS ANTIGEN 85A; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT BCG VACCINE; RECOMBINANT VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VECTOR; ACYLTRANSFERASE; ANTIGEN 85A, MYCOBACTERIUM TUBERCULOSIS; BACTERIAL ANTIGEN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TREATMENT RESPONSE; ANIMAL; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENETICS; IMMUNOLOGY; METABOLISM; TUBERCULIN TEST; VACCINIA VIRUS;

ACYLTRANSFERASES; ANIMALS; ANTIGENS, BACTERIAL; BCG VACCINE; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC ENGINEERING; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; RECOMBINANT PROTEINS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; VACCINIA VIRUS;

EID: 60549091001     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00685-08     Document Type: Article

References (25)

1. Darrah, P. A., D. T. Patel, P. M. De Luca, R. W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, M. Roederer, and R. A. Seder. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13:843-850.
2. Desel, C. 2008. Evaluation of novel vaccine candidates against tuberculosis in murine models of persistent and latent infection. Ph.D. thesis. Technische Universitaet Berlin, Berlin, Germany.
3. D'Souza, S., V. Rosseels, M. Romano, A. Tanghe, O. Denis, F. Jurion, N. Castiglione, A. Vanonckelen, K. Palfliet, and K. Huygen. 2003. Mapping of murine Thl helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis. Infect. lmmun. 71:483-493.
4. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom, 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
5. Forbes, E. K., C. Sander, E. O. Ronan, H. McShane, A. V. Hill, P. C. Beverley, and E. Z. Tchilian. 2008. Multifunctional, high-level cytokine- producing Thl cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J. Immunol. 181:4955-4964.
6. Goonetilleke, N. P., H. McShane, C. M. Hannan, R. J. Anderson, R. H. Brookes, and A. V. Hill. 2003. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J. Immunol. 171:1602-1609.
7. Grode, L., P. Seiler, S. Baumann, J. Hess, V. Brinkmann, A. Nasser Eddine, P. Mann, C. Goosmann, S. Bandermann, D. Smith, G. J. Bancroft, J. M. Reyrat, D. van Soolingen, B. Raupach, and S. H. Kaufmann. 2005. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J. Clin. Investig. 115:2472-2479.
8. Gruppo, V., and I. M. Orme. 2002. Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with Mycobacterium tuberculosis. Tuberculosis (Edinburgh) 82:267-273.
9. Hess, J., D. Miko, A. Catic, V. Lehmensiek, D. G. Russell, and S. H. Kaufmann. 1998. Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc. Natl. Acad. Sci. USA 95:5299- 5304.
10. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R, R. Deck, C. M. DeWitt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J. P. Van Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898.
11. Huygen, K., E. Lozes, B. Gilles, A. Drowart, K. Palfliet, F. Jurion, I. Roland, M. Art, M. Dufaux, J. Nyabenda, J. De Bruyn, J.-P. Van Vooren, and R. DeLeys. 1994. Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect. lmmun. 62:363-370.
12. Lozes, E., K. Huygen, J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, P. Vandenbussche, J. P. Van Vooren, A. Drowart, J. B. Ulmer, and M. A, Liu. 1997. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 15: 830-833.
13. McShane, H-, A. A. Pathan, C. R. Sander, S. M. Keating, S. C. Gilbert, K. Huygen, H, A. Fletcher, and A, V. Hill, 2004. Recombinant modified vaccinia vims Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med. 10:1240-1244.
14. + T-cell epitopes from antigen 85A. Infect. lmmun. 70:1623-1626.
15. Mittrucker, H. W., U. Steinhoff, A. Kohler, M. Krause, D. Lazar, P, Mex, D. Miekley, and S. H. Kaufmann. 2007. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc. Nad. Acad. Sci. USA 104:12434-12439.
16. Palendira, U., A. G. Bean, C. G. Feng, and W. J. Britton. 2002. Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization. Infect. lmmun. 70:1410-1416.
17. Radosevic, K., C. W. Wieland, A. Rodriguez, G. J. Weverling, R. Mintardjo, G. Gillissen, R. Vogels, Y. A. Skeiky, D. M, Hone, J. C. Sadoff, T. van der Poll, M. Havenga, and J. Goudsmit. 2007. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CDS T-cell epitope mapping and role of gamma interferon. Infect, lmmun. 75:4105-4115.
18. Romano, M., S. D'Souza, P. Y. Adnet, R. Laali, F. Jurion, K. Palfliet, and K. Huygen. 2006. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Vaccine 24:3353-3364.
19. Santosuosso, M., S. McCormick, E. Roediger, X. Zhang, A. Zganiacz, B. D. Lichty, and Z. Xing. 2007. Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization. J. Immunol. 178:2387-2395.
20. Santosuosso, M., S. McCormick, X. Zhang, A. Zganiacz, and Z. Xing. 2006. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect. lmmun. 74:4634-4643.
21. Trunz, B. B., P. Fine, and C. Dye. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367:1173-1180.
22. Vordermeier, H. M-, S. G. Rhodes, G. Dean, N. Goonetilleke, K. Huygen, A. V. Hill, R. G. Hewinson, and S. C, Gilbert. 2004. Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin. Immunology 112: 461-470.
23. Wedlock, D. N., M. Denis, H. M. Vordermeier, R. G. Hewinson, and B. M. Buddie. 2007. Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vac-titration, but induce similar levels of protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 118:50-58.
24. Whelan, A. O., D. C. Wright, M. A. Chambers, M. Singh, R. G, Hewinson, and H. M. Vordermeier. 2008. Evidence for enhanced central memoiy priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations. Vaccine 26:166-173.
25. World Health Organization. 2007. Global tuberculosis control-surveillance, planning, financing. WHO Report 2007, WHO/HTM/TB/2007.376. World Health Organization, Geneva, Switzerland.